Cargando…

The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer

BACKGROUND: Patients with triple-negative breast cancer (TNBC) have poor overall survival. The present study aimed to investigate the potential prognostics of TNBC by analyzing breast cancer proteomic and transcriptomic datasets. METHODS: Candidate proteins selected from CPTAC (the National Cancer I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qianxue, Tang, Xin, Zhu, Wenming, Li, Qing, Zhang, Xiang, Li, Hongyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634334/ https://www.ncbi.nlm.nih.gov/pubmed/34868954 http://dx.doi.org/10.3389/fonc.2021.751430

Ejemplares similares

A structural analysis of DNA binding by hSSB1 (NABP2/OBFC2B) in solution
por: Touma, Christine, et al.
Publicado: (2016)

Identification of autophagy‐related long non‐coding RNA prognostic signature for breast cancer
por: Wu, Qianxue, et al.
Publicado: (2021)

hSSB1 (NABP2/OBFC2B) is regulated by oxidative stress
por: Paquet, Nicolas, et al.
Publicado: (2016)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

Epsin 3 potentiates the NF-κB signaling pathway to regulate apoptosis in breast cancer
por: Wu, Qianxue, et al.
Publicado: (2022)

A data-driven structural model of hSSB1 (NABP2/OBFC2B) self-oligomerization
por: Touma, Christine, et al.
Publicado: (2017)

Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer
por: Li, Meng, et al.
Publicado: (2022)

The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer
por: Melo, Carina Mucciolo, et al.
Publicado: (2021)

Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
por: Wu, Song, et al.
Publicado: (2022)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022)

A Structural Perspective on the Regulation of Human Single-Stranded DNA Binding Protein 1 (hSSB1, OBFC2B) Function in DNA Repair
por: Lawson, Teegan, et al.
Publicado: (2019)

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
por: Wu, Qiang, et al.
Publicado: (2019)

Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer
por: Qin, Wenxing, et al.
Publicado: (2021)

Association of TERC and OBFC1 Haplotypes with Mean Leukocyte Telomere Length and Risk for Coronary Heart Disease
por: Maubaret, Cécilia G., et al.
Publicado: (2013)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Correlation between the Warburg effect and progression of triple-negative breast cancer
por: Liu, Shaojun, et al.
Publicado: (2023)

Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells
por: Li, Xinyang, et al.
Publicado: (2022)

Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
por: Hu, Xueyi, et al.
Publicado: (2023)

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
por: Tan, Qiaorui, et al.
Publicado: (2022)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Li, Yunhai, et al.
Publicado: (2021)

Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging
por: Phillips, Leo, et al.
Publicado: (2019)

The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer
por: Zhou, Yueyuan, et al.
Publicado: (2022)

Prognostic Factor Analysis and Model Construction of Triple-Negative Metaplastic Breast Carcinoma After Surgery
por: Zhu, Keying, et al.
Publicado: (2022)

Determining prognostic factors and optimal surgical intervention for early-onset triple-negative breast cancer
por: Zheng, Yi-Zi, et al.
Publicado: (2022)

A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
por: A, Ruhan, et al.
Publicado: (2023)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
por: Cui, Xiang, et al.
Publicado: (2021)

Relationship between the TERT, TNIP1 and OBFC1 genetic polymorphisms and susceptibility to colorectal cancer in Chinese Han population
por: Li, Chuang, et al.
Publicado: (2017)

CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
por: Zhang, Lianmei, et al.
Publicado: (2023)

Spatial Profiling Identifies Prognostic Features of Response to Adjuvant Therapy in Triple Negative Breast Cancer (TNBC)
por: Kulasinghe, Arutha, et al.
Publicado: (2022)

Verification and Validation of a Four-Gene Panel as a Prognostic Indicator in Triple Negative Breast Cancer
por: Pariyar, Mamta, et al.
Publicado: (2022)

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
por: Zhu, Youzhi, et al.
Publicado: (2023)

Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer
por: Cui, Xiang, et al.
Publicado: (2020)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation
por: Zhang, Zhen
Publicado: (2022)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7qt5b8o8orr3n0o3tekc806hbp